Target intelligence / Profile preview

Solute carrier family 25 member 41 (SLC25A41)

Target
SLC25A41
Molecular classification
Transporter, Mitochondrial carrier (MCF motif-containing protein), Solute carrier family (SLC family)
01

Overview

Solute carrier family 25 member 41 (SLC25A41) is a mitochondrial inner membrane transporter that belongs to the extensive SLC25 family, also known as the mitochondrial carrier family (MCF)[4]. These carriers are integral membrane proteins containing six transmembrane helices and a characteristic MCF signature motif[3]. While SLC25A41 has several transcript variants and may be referred to by multiple alternative names (e.g., SCaMC-3L), its precise substrate is not well characterized. Broadly, SLC25 proteins facilitate the exchange of various metabolites, nucleotides, and cofactors necessary for mitochondrial and cellular energy metabolism, often operating via antiport or symport mechanisms. The family as a whole is crucial for mitochondrial function and cell viability[1][2][4]. Although dysfunctions in related SLC25 transporters are implicated in several inherited metabolic diseases, there is no direct evidence to date linking SLC25A41 itself to specific human pathologies or targeted drug therapies.

Other names
Mitochondrial carrier protein SCaMC-3LSCaMC-3-likeSCaMC-3LFLJ40442MGC34725APC4Mitochondrial ATP-Mg/Pi carrier protein SLC25A41Small calcium-binding mitochondrial carrier protein 3-likeSolute carrier family 25 member 41
02

Mechanism of action

Not applicable (no known specific drugs; general mechanism for the family is antiport/symport/uniport of mitochondrial metabolites)

03

Biological functions

Transport of solutes (putatively nucleotides, metabolites) across the mitochondrial inner membraneMitochondrial energy metabolismMaintenance of cellular homeostasis
04

Disease associations

Other (No direct well-characterized disease associations reported for SLC25A41 specifically; some SLC25 members are linked to inherited metabolic or mitochondrial diseases)

Beyond the preview

Go deeper on Solute carrier family 25 member 41 (SLC25A41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 41 (SLC25A41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call